Recurrent Fallopian Tube Mucinous Adenocarcinoma

specific

The reemergence of fallopian tube mucinous adenocarcinoma after a period of remission.

35

Centers

35

Active Trials

Cancer Funding

Top Centers for Recurrent Fallopian Tube Mucinous Adenocarcinoma(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.4
2
NCI Comprehensive
Active Research Program
51.4
3
NCI Comprehensive
Active Research Program
51.4
4
NCI Comprehensive
Active Research Program
51.4
5
NCI Comprehensive
Active Research Program
51.4
6
NCI Comprehensive
Active Research Program
51.4
751.4
8
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.4
9
NCI Comprehensive
Active Research Program
51.4
10
NCI Comprehensive
Active Research Program
51.4
11
NCI Comprehensive
Active Research Program
51.4
12
NCI Comprehensive
Active Research Program
51.4
13
NCI Comprehensive
Active Research Program
51.4
14
NCI Comprehensive
Active Research Program
51.4
15
NCI Comprehensive
Active Research Program
51.4
16
NCI Clinical
Active Research Program
51.4
17
NCI Comprehensive
Active Research Program
51.4
18
Active Research Program
51.4
19
Active Research Program
51.4
20
NCI Comprehensive
Active Research Program
51.4
21
NCI Clinical
Active Research Program
51.4
22
NCI Comprehensive
Active Research Program
51.4
23
Active Research Program
51.4
24
NCI Clinical
Active Research Program
51.4
25
NCI Comprehensive
Active Research Program
51.4
26
Active Research Program
51.4
2751.4
28
Active Research Program
51.4
29
Active Research Program
51.4
30
Active Research Program
51.4
31
Active Research Program
51.4
3251.4
33
Active Research Program
51.4
34
Active Research Program
51.4
35
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →